Yurttaş, LeylaErtaş, MerveAkalın Çiftçi, GülşenTemel, Halide EdipDemirayak, Şeref10.07.20192019-07-1010.07.20192019-07-102017Yurttaş, L., Ertaş, M., Akalın Çiftçi, G., Temel, H. E. ve Demirayak, Ş. (2017). Novel benzothiazole based imidazole derivatives as new cytotoxic agents against glioma (C6) and liver (HepG2) cancer cell lines. Acta Pharmaceutica Sciencia, 55(1), 39-47. https://dx.doi.org/10.23893/1307-2080.APS.05531307-2080https://hdl.handle.net/20.500.12511/1106https://dx.doi.org/10.23893/1307-2080.APS.0553In this work, some novel N-(6-substituted-benzothiazol-2-yl)-2-[[4,5-dimethyl-1-((p-tolyl/4-nitrophenyl)amino)-1H-imidazol-2-yl]thio]acetamide derivatives were synthesized and searched for their cytotoxic activities against C6 and HepG2 tumor cells. Among all compounds, the most active compound was determined as compound 7. It was calculated IC50 value about 15.67 µg/mL through C6 tumor cell lines and also compound 2, 4, 5, 6 were observed as good cytotoxic agents against HepG2 tumor cells. Findings about antiproliferative activity studies have encouraged the acquirement of new similar compounds in undergoing studies.eninfo:eu-repo/semantics/openAccessAntiproliferative ActivityBenzothiazoleCytotoxicityImidazoleArticle551394710.23893/1307-2080.APS.0553Q4